Prismic Pharmaceuticals

Prismic Pharmaceuticals is a specialty pharmaceutical company that focuses on the research and development of proprietary products with unique safety profiles to address inflammation and oxidative stress, which are thought to be underlying causes of many of the most commonly occurring disorders, and particularly those associated with the aging population.

Primsic currently has two pharmaceutically active ingredients, ultra-micronized palmitoylethanolamide, and ultra-pure EPA-based Omega-3, in development to address disorders associated with kidney disease, mental health, and chronic pain.

The company was founded in 2011 by industry veterans, Peter Moriarty (Warner-Lambert, Schering-Plough, and Shire Co-Founder); Zachary Dutton (Laxdale, Efamol, Primus); and Danilo Casadei Massari (Fidia, CM&D Founder).